Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • StackAI Reviews & Ratings
    37 Ratings
    Company Website
  • PathSolutions TotalView Reviews & Ratings
    42 Ratings
    Company Website
  • RaimaDB Reviews & Ratings
    5 Ratings
    Company Website
  • Windocks Reviews & Ratings
    7 Ratings
    Company Website
  • Google Cloud Platform Reviews & Ratings
    60,419 Ratings
    Company Website
  • dbt Reviews & Ratings
    197 Ratings
    Company Website
  • SalesTarget.ai Reviews & Ratings
    13 Ratings
    Company Website
  • Boozang Reviews & Ratings
    15 Ratings
    Company Website
  • JetBrains Junie Reviews & Ratings
    2 Ratings
    Company Website
  • D&B Connect Reviews & Ratings
    181 Ratings
    Company Website

What is SpliceCore?

Utilizing RNA sequencing (RNA-seq) data in conjunction with Artificial Intelligence offers both an essential need and a remarkable opportunity for developing therapies that target splicing errors. By harnessing machine learning techniques, we can identify new splicing errors and promptly create therapeutic compounds to rectify these issues. Our specialized AI platform, SpliceCore, is dedicated to the discovery of RNA-based therapeutics. This advanced technology excels in analyzing RNA sequencing data with exceptional speed and accuracy. It effectively identifies, assesses, and confirms potential drug targets, surpassing conventional methods in efficiency. A key feature of SpliceCore is our proprietary database, which houses over 5 million potential RNA splicing errors, making it the largest resource of its type worldwide and vital for evaluating any RNA sequencing dataset submitted for analysis. The incorporation of scalable cloud computing enables us to manage extensive RNA sequencing data efficiently and economically, thereby accelerating the development of new therapies. This groundbreaking strategy is set to transform the field of RNA therapeutics, paving the way for unprecedented advancements in treatment options. As we move forward, the potential for discovery in this domain continues to expand, promising a future filled with innovative solutions.

What is SILCS?

Site-Identification by Ligand Competitive Saturation (SILCS) generates three-dimensional representations called FragMaps, which depict the interactions of various chemical functional groups with a designated target molecule. By uncovering the intricacies of molecular dynamics, SILCS provides essential tools that facilitate the refinement of ligand scaffolds, offering both qualitative and quantitative perspectives on binding sites, which ultimately aids in optimizing the drug design workflow. This methodology utilizes a selection of small molecule probes, each possessing a variety of functional groups, along with explicit solvent modeling and the flexibility of the target molecule to effectively map protein targets. Moreover, the technique empowers researchers to visualize beneficial interactions with the target macromolecule, allowing for a more informed design process. Armed with these insights, scientists can strategically engineer enhanced ligands with functional groups positioned for maximum efficacy. The pioneering approach of SILCS marks a noteworthy leap forward in the realm of medicinal chemistry, opening new avenues for drug discovery and development. Through its advanced analytical capabilities, SILCS not only enhances understanding but also drives innovation in therapeutic design.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

Has API

API Availability

Has API

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Envisagenics

Date Founded

2014

Company Location

United States

Company Website

www.envisagenics.com/platform/

Company Facts

Organization Name

SilcsBio

Date Founded

2012

Company Location

United States

Company Website

silcsbio.com/software/

Categories and Features

Categories and Features

Popular Alternatives

Popular Alternatives

3decision Reviews & Ratings

3decision

Discngine
BIOiSIM Reviews & Ratings

BIOiSIM

VERISIMLife
Aurora Drug Discovery Reviews & Ratings

Aurora Drug Discovery

Aurora Fine Chemicals
BioNeMo Reviews & Ratings

BioNeMo

NVIDIA